MCF Advisors’s NeueHealth NEUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-125
| Closed | -$834 | – | 1189 |
|
|
2025
Q3 | $834 | Sell |
125
-125
| -50% | -$842 | ﹤0.01% | 911 |
|
|
2025
Q2 | $1.73K | Hold |
250
| – | – | ﹤0.01% | 819 |
|
|
2025
Q1 | $1.69K | Hold |
250
| – | – | ﹤0.01% | 820 |
|
|
2024
Q4 | $1.85K | Hold |
250
| – | – | ﹤0.01% | 854 |
|
|
2024
Q3 | $1.3K | Hold |
250
| – | – | ﹤0.01% | 881 |
|
|
2024
Q2 | $1.36K | Hold |
250
| – | – | ﹤0.01% | 879 |
|
|
2024
Q1 | $1.63K | Hold |
250
| – | – | ﹤0.01% | 838 |
|
|
2023
Q4 | $1.91K | Hold |
250
| – | – | ﹤0.01% | 783 |
|
|
2023
Q3 | $1.49K | Hold |
250
| – | – | ﹤0.01% | 797 |
|
|
2023
Q2 | $3.06K | Hold |
250
| – | – | ﹤0.01% | 671 |
|
|
2023
Q1 | $4.41K | Hold |
250
| – | – | ﹤0.01% | 636 |
|
|
2022
Q4 | $13K | Hold |
250
| – | – | ﹤0.01% | 505 |
|
|
2022
Q3 | $21K | Hold |
250
| – | – | ﹤0.01% | 455 |
|
|
2022
Q2 | $36K | Sell |
250
-125
| -33% | -$18.2K | ﹤0.01% | 362 |
|
|
2022
Q1 | $58K | Buy |
+375
| New | +$83.3K | 0.01% | 309 |
|
|
2021
Q4 | – | Sell |
-350
| Closed | -$228K | – | 717 |
|
|
2021
Q3 | $228K | Buy |
+350
| New | +$308K | 0.02% | 170 |
|
MCF Advisors's NEUE Position: Q4 2025 in Review
MCF Advisors sold out of NeueHealth (NEUE) in Q4 2025, closing a stake of 125 shares — an estimated $834 sold.
MCF Advisors first reported a position in NEUE in Q3 2021 and held it in 16 quarters. The position peaked at $228K in Q3 2021. 0 funds tracked by Wall St. Rank hold NEUE as of Q4 2025.
- MCF Advisors reported no remaining NeueHealth position as of Q4 2025 after selling out during the quarter.
- MCF Advisors sold 125 NeueHealth shares in Q4 2025, an estimated $834.
- MCF Advisors first reported a position in NeueHealth in Q3 2021 and held it in 16 quarters.
- MCF Advisors's NeueHealth position peaked at $228K in Q3 2021.
- 0 funds tracked by Wall St. Rank held NeueHealth as of Q4 2025.
Based on MCF Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.